nodes	percent_of_prediction	percent_of_DWPC	metapath
Risperidone—CYP2D6—breast cancer	0.0926	0.389	CbGaD
Risperidone—CYP3A4—breast cancer	0.0794	0.333	CbGaD
Risperidone—ABCB1—breast cancer	0.0661	0.278	CbGaD
Risperidone—HTR2B—Raloxifene—breast cancer	0.0455	0.116	CbGbCtD
Risperidone—CYP3A5—Lapatinib—breast cancer	0.0191	0.0486	CbGbCtD
Risperidone—ABCB1—Toremifene—breast cancer	0.0171	0.0433	CbGbCtD
Risperidone—CYP3A4—Exemestane—breast cancer	0.0147	0.0375	CbGbCtD
Risperidone—CYP2D6—Idarubicin—breast cancer	0.0133	0.0338	CbGbCtD
Risperidone—CYP3A7—Tamoxifen—breast cancer	0.0128	0.0324	CbGbCtD
Risperidone—CYP3A7-CYP3A51P—Tamoxifen—breast cancer	0.0128	0.0324	CbGbCtD
Risperidone—CYP3A4—Letrozole—breast cancer	0.0125	0.0319	CbGbCtD
Risperidone—ABCB1—Lapatinib—breast cancer	0.0124	0.0316	CbGbCtD
Risperidone—CYP3A4—Anastrozole—breast cancer	0.0112	0.0284	CbGbCtD
Risperidone—CYP3A4—Toremifene—breast cancer	0.0102	0.026	CbGbCtD
Risperidone—CYP3A7-CYP3A51P—Paclitaxel—breast cancer	0.00994	0.0252	CbGbCtD
Risperidone—CYP3A7—Paclitaxel—breast cancer	0.00994	0.0252	CbGbCtD
Risperidone—CYP3A7-CYP3A51P—Irinotecan—breast cancer	0.0098	0.0249	CbGbCtD
Risperidone—CYP3A7—Irinotecan—breast cancer	0.0098	0.0249	CbGbCtD
Risperidone—CYP3A5—Tamoxifen—breast cancer	0.00958	0.0243	CbGbCtD
Risperidone—CYP3A4—Fulvestrant—breast cancer	0.0095	0.0241	CbGbCtD
Risperidone—CYP3A4—Thiotepa—breast cancer	0.00847	0.0215	CbGbCtD
Risperidone—CYP3A4—Ixabepilone—breast cancer	0.00775	0.0197	CbGbCtD
Risperidone—CYP3A4—Lapatinib—breast cancer	0.00746	0.0189	CbGbCtD
Risperidone—CYP3A5—Paclitaxel—breast cancer	0.00745	0.0189	CbGbCtD
Risperidone—CYP3A5—Irinotecan—breast cancer	0.00735	0.0187	CbGbCtD
Risperidone—CYP3A7—Docetaxel—breast cancer	0.00718	0.0182	CbGbCtD
Risperidone—CYP3A7-CYP3A51P—Docetaxel—breast cancer	0.00718	0.0182	CbGbCtD
Risperidone—ABCB1—Vinorelbine—breast cancer	0.0069	0.0175	CbGbCtD
Risperidone—CYP2D6—Vinorelbine—breast cancer	0.00651	0.0165	CbGbCtD
Risperidone—ABCB1—Tamoxifen—breast cancer	0.00623	0.0158	CbGbCtD
Risperidone—ABCB1—Mitoxantrone—breast cancer	0.00608	0.0154	CbGbCtD
Risperidone—CYP2D6—Tamoxifen—breast cancer	0.00587	0.0149	CbGbCtD
Risperidone—CYP3A4—Raloxifene—breast cancer	0.00565	0.0144	CbGbCtD
Risperidone—CYP3A5—Docetaxel—breast cancer	0.00539	0.0137	CbGbCtD
Risperidone—ABCB1—Gemcitabine—breast cancer	0.00537	0.0136	CbGbCtD
Risperidone—ABCB1—Paclitaxel—breast cancer	0.00485	0.0123	CbGbCtD
Risperidone—ABCB1—Irinotecan—breast cancer	0.00479	0.0122	CbGbCtD
Risperidone—ABCB1—Vinblastine—breast cancer	0.00425	0.0108	CbGbCtD
Risperidone—CYP3A4—Vinorelbine—breast cancer	0.00414	0.0105	CbGbCtD
Risperidone—CYP2D6—Vinblastine—breast cancer	0.00401	0.0102	CbGbCtD
Risperidone—CYP3A4—Tamoxifen—breast cancer	0.00373	0.00949	CbGbCtD
Risperidone—CYP3A4—Mitoxantrone—breast cancer	0.00364	0.00925	CbGbCtD
Risperidone—ABCB1—Docetaxel—breast cancer	0.00351	0.00891	CbGbCtD
Risperidone—CYP3A4—Paclitaxel—breast cancer	0.00291	0.00738	CbGbCtD
Risperidone—CYP3A4—Irinotecan—breast cancer	0.00287	0.00728	CbGbCtD
Risperidone—ABCB1—Doxorubicin—breast cancer	0.00261	0.00664	CbGbCtD
Risperidone—CYP3A4—Vinblastine—breast cancer	0.00255	0.00648	CbGbCtD
Risperidone—ABCB1—Methotrexate—breast cancer	0.00253	0.00643	CbGbCtD
Risperidone—CYP2D6—Doxorubicin—breast cancer	0.00246	0.00626	CbGbCtD
Risperidone—CYP3A4—Docetaxel—breast cancer	0.0021	0.00534	CbGbCtD
Risperidone—CYP3A4—Doxorubicin—breast cancer	0.00157	0.00398	CbGbCtD
Risperidone—H1F0—mammary gland—breast cancer	0.00106	0.0381	CbGeAlD
Risperidone—H1F0—nipple—breast cancer	0.000881	0.0315	CbGeAlD
Risperidone—H1F0—embryo—breast cancer	0.000727	0.026	CbGeAlD
Risperidone—H1F0—skin of body—breast cancer	0.000564	0.0202	CbGeAlD
Risperidone—H1F0—endometrium—breast cancer	0.000532	0.019	CbGeAlD
Risperidone—KCNH2—nipple—breast cancer	0.000506	0.0181	CbGeAlD
Risperidone—CYP3A7—endocrine gland—breast cancer	0.000503	0.018	CbGeAlD
Risperidone—ADRA2C—nipple—breast cancer	0.0005	0.0179	CbGeAlD
Risperidone—H1F0—uterus—breast cancer	0.00049	0.0175	CbGeAlD
Risperidone—H1F0—pituitary gland—breast cancer	0.000481	0.0172	CbGeAlD
Risperidone—H1F0—adipose tissue—breast cancer	0.000479	0.0171	CbGeAlD
Risperidone—H1F0—female reproductive system—breast cancer	0.000441	0.0158	CbGeAlD
Risperidone—H1F0—adrenal gland—breast cancer	0.00043	0.0154	CbGeAlD
Risperidone—H1F0—bone marrow—breast cancer	0.000416	0.0149	CbGeAlD
Risperidone—HTR2B—skin of body—breast cancer	0.000406	0.0145	CbGeAlD
Risperidone—HRH1—nipple—breast cancer	0.000406	0.0145	CbGeAlD
Risperidone—H1F0—female gonad—breast cancer	0.000401	0.0143	CbGeAlD
Risperidone—ADRA2A—nipple—breast cancer	0.000399	0.0143	CbGeAlD
Risperidone—HTR2B—endometrium—breast cancer	0.000383	0.0137	CbGeAlD
Risperidone—H1F0—endocrine gland—breast cancer	0.000373	0.0133	CbGeAlD
Risperidone—Paliperidone—CYP2D6—breast cancer	0.00037	0.317	CrCbGaD
Risperidone—HTR7—epithelium—breast cancer	0.000366	0.0131	CbGeAlD
Risperidone—HTR2B—uterus—breast cancer	0.000353	0.0126	CbGeAlD
Risperidone—ADRA1A—epithelium—breast cancer	0.000353	0.0126	CbGeAlD
Risperidone—HTR1B—female reproductive system—breast cancer	0.000352	0.0126	CbGeAlD
Risperidone—HTR2B—adipose tissue—breast cancer	0.000345	0.0124	CbGeAlD
Risperidone—HTR1D—female reproductive system—breast cancer	0.000341	0.0122	CbGeAlD
Risperidone—HTR2C—female reproductive system—breast cancer	0.000338	0.0121	CbGeAlD
Risperidone—Paliperidone—CYP3A4—breast cancer	0.000317	0.272	CrCbGaD
Risperidone—HTR2B—female reproductive system—breast cancer	0.000317	0.0114	CbGeAlD
Risperidone—HTR2B—adrenal gland—breast cancer	0.00031	0.0111	CbGeAlD
Risperidone—KCNH2—endometrium—breast cancer	0.000306	0.0109	CbGeAlD
Risperidone—ADRA2C—endometrium—breast cancer	0.000302	0.0108	CbGeAlD
Risperidone—HTR1B—endocrine gland—breast cancer	0.000298	0.0107	CbGeAlD
Risperidone—ADRA1A—adipose tissue—breast cancer	0.000285	0.0102	CbGeAlD
Risperidone—KCNH2—uterus—breast cancer	0.000282	0.0101	CbGeAlD
Risperidone—DRD2—pituitary gland—breast cancer	0.000281	0.01	CbGeAlD
Risperidone—HTR2A—embryo—breast cancer	0.00028	0.01	CbGeAlD
Risperidone—ADRA2C—uterus—breast cancer	0.000278	0.00994	CbGeAlD
Risperidone—HTR1A—adrenal gland—breast cancer	0.000278	0.00993	CbGeAlD
Risperidone—KCNH2—pituitary gland—breast cancer	0.000277	0.0099	CbGeAlD
Risperidone—HRH1—epithelium—breast cancer	0.000273	0.00977	CbGeAlD
Risperidone—ADRA2C—pituitary gland—breast cancer	0.000273	0.00976	CbGeAlD
Risperidone—HTR7—female reproductive system—breast cancer	0.000272	0.00972	CbGeAlD
Risperidone—ADRA2C—adipose tissue—breast cancer	0.000272	0.00972	CbGeAlD
Risperidone—HTR7—adrenal gland—breast cancer	0.000265	0.00949	CbGeAlD
Risperidone—Iloperidone—CYP2D6—breast cancer	0.000259	0.222	CrCbGaD
Risperidone—H1F0—lymph node—breast cancer	0.000258	0.00922	CbGeAlD
Risperidone—ADRA1A—adrenal gland—breast cancer	0.000256	0.00915	CbGeAlD
Risperidone—KCNH2—female reproductive system—breast cancer	0.000253	0.00906	CbGeAlD
Risperidone—KCNH2—adrenal gland—breast cancer	0.000247	0.00884	CbGeAlD
Risperidone—HRH1—endometrium—breast cancer	0.000245	0.00876	CbGeAlD
Risperidone—ADRA2C—adrenal gland—breast cancer	0.000244	0.00872	CbGeAlD
Risperidone—HTR1A—endocrine gland—breast cancer	0.000241	0.00861	CbGeAlD
Risperidone—ADRA2A—endometrium—breast cancer	0.000241	0.00861	CbGeAlD
Risperidone—KCNH2—bone marrow—breast cancer	0.000239	0.00855	CbGeAlD
Risperidone—KCNH2—female gonad—breast cancer	0.00023	0.00824	CbGeAlD
Risperidone—HTR7—endocrine gland—breast cancer	0.00023	0.00823	CbGeAlD
Risperidone—HTR2A—epithelium—breast cancer	0.000228	0.00816	CbGeAlD
Risperidone—CYP3A5—adipose tissue—breast cancer	0.000227	0.00814	CbGeAlD
Risperidone—ADRA2C—female gonad—breast cancer	0.000227	0.00813	CbGeAlD
Risperidone—Iloperidone—CYP3A4—breast cancer	0.000222	0.19	CrCbGaD
Risperidone—ADRA1A—endocrine gland—breast cancer	0.000222	0.00794	CbGeAlD
Risperidone—ADRA2A—uterus—breast cancer	0.000222	0.00793	CbGeAlD
Risperidone—HRH1—adipose tissue—breast cancer	0.000221	0.0079	CbGeAlD
Risperidone—ADRA2A—pituitary gland—breast cancer	0.000218	0.00779	CbGeAlD
Risperidone—DRD2—endocrine gland—breast cancer	0.000217	0.00778	CbGeAlD
Risperidone—ADRA2A—adipose tissue—breast cancer	0.000217	0.00776	CbGeAlD
Risperidone—KCNH2—endocrine gland—breast cancer	0.000214	0.00767	CbGeAlD
Risperidone—HRH1—female reproductive system—breast cancer	0.000203	0.00726	CbGeAlD
Risperidone—ADRA2A—female reproductive system—breast cancer	0.000199	0.00713	CbGeAlD
Risperidone—HRH1—adrenal gland—breast cancer	0.000198	0.00709	CbGeAlD
Risperidone—ADRA2A—adrenal gland—breast cancer	0.000195	0.00696	CbGeAlD
Risperidone—CYP3A5—female gonad—breast cancer	0.00019	0.00681	CbGeAlD
Risperidone—HTR2B—lymph node—breast cancer	0.000186	0.00664	CbGeAlD
Risperidone—HTR2A—pituitary gland—breast cancer	0.000185	0.00662	CbGeAlD
Risperidone—HRH1—female gonad—breast cancer	0.000185	0.00661	CbGeAlD
Risperidone—ABCB1—embryo—breast cancer	0.000183	0.00656	CbGeAlD
Risperidone—ADRA2A—female gonad—breast cancer	0.000181	0.00649	CbGeAlD
Risperidone—CYP3A5—endocrine gland—breast cancer	0.000177	0.00633	CbGeAlD
Risperidone—HRH1—endocrine gland—breast cancer	0.000172	0.00614	CbGeAlD
Risperidone—HTR2A—female reproductive system—breast cancer	0.00017	0.00606	CbGeAlD
Risperidone—ADRA2A—endocrine gland—breast cancer	0.000169	0.00604	CbGeAlD
Risperidone—HTR2A—adrenal gland—breast cancer	0.000165	0.00592	CbGeAlD
Risperidone—CYP3A4—female reproductive system—breast cancer	0.000157	0.00561	CbGeAlD
Risperidone—CYP2D6—female reproductive system—breast cancer	0.000154	0.00552	CbGeAlD
Risperidone—ABCB1—epithelium—breast cancer	0.00015	0.00535	CbGeAlD
Risperidone—KCNH2—lymph node—breast cancer	0.000148	0.0053	CbGeAlD
Risperidone—ADRA2C—lymph node—breast cancer	0.000146	0.00523	CbGeAlD
Risperidone—HTR2A—endocrine gland—breast cancer	0.000143	0.00513	CbGeAlD
Risperidone—CYP2D6—female gonad—breast cancer	0.000141	0.00503	CbGeAlD
Risperidone—ABCB1—endometrium—breast cancer	0.000134	0.0048	CbGeAlD
Risperidone—CYP3A4—endocrine gland—breast cancer	0.000133	0.00475	CbGeAlD
Risperidone—CYP2D6—endocrine gland—breast cancer	0.000131	0.00467	CbGeAlD
Risperidone—ABCB1—uterus—breast cancer	0.000124	0.00442	CbGeAlD
Risperidone—ABCB1—pituitary gland—breast cancer	0.000121	0.00434	CbGeAlD
Risperidone—ABCB1—adipose tissue—breast cancer	0.000121	0.00432	CbGeAlD
Risperidone—HRH1—lymph node—breast cancer	0.000119	0.00425	CbGeAlD
Risperidone—ADRA2A—lymph node—breast cancer	0.000117	0.00417	CbGeAlD
Risperidone—ABCB1—female reproductive system—breast cancer	0.000111	0.00397	CbGeAlD
Risperidone—ABCB1—adrenal gland—breast cancer	0.000108	0.00388	CbGeAlD
Risperidone—ABCB1—bone marrow—breast cancer	0.000105	0.00375	CbGeAlD
Risperidone—ABCB1—female gonad—breast cancer	0.000101	0.00362	CbGeAlD
Risperidone—ABCB1—endocrine gland—breast cancer	9.4e-05	0.00336	CbGeAlD
Risperidone—ABCB1—lymph node—breast cancer	6.5e-05	0.00232	CbGeAlD
Risperidone—Urethral disorder—Doxorubicin—breast cancer	1.65e-05	7.05e-05	CcSEcCtD
Risperidone—Nausea—Irinotecan—breast cancer	1.65e-05	7.04e-05	CcSEcCtD
Risperidone—Nausea—Mitoxantrone—breast cancer	1.65e-05	7.04e-05	CcSEcCtD
Risperidone—Immune system disorder—Epirubicin—breast cancer	1.65e-05	7.02e-05	CcSEcCtD
Risperidone—Mediastinal disorder—Epirubicin—breast cancer	1.64e-05	7.01e-05	CcSEcCtD
Risperidone—Constipation—Docetaxel—breast cancer	1.64e-05	7e-05	CcSEcCtD
Risperidone—Pain—Docetaxel—breast cancer	1.64e-05	7e-05	CcSEcCtD
Risperidone—Back pain—Methotrexate—breast cancer	1.64e-05	7e-05	CcSEcCtD
Risperidone—Dyspepsia—Capecitabine—breast cancer	1.64e-05	6.98e-05	CcSEcCtD
Risperidone—Chills—Epirubicin—breast cancer	1.64e-05	6.98e-05	CcSEcCtD
Risperidone—Arrhythmia—Epirubicin—breast cancer	1.63e-05	6.95e-05	CcSEcCtD
Risperidone—Visual impairment—Doxorubicin—breast cancer	1.63e-05	6.93e-05	CcSEcCtD
Risperidone—Asthenia—Paclitaxel—breast cancer	1.62e-05	6.93e-05	CcSEcCtD
Risperidone—Decreased appetite—Capecitabine—breast cancer	1.62e-05	6.89e-05	CcSEcCtD
Risperidone—Alopecia—Epirubicin—breast cancer	1.61e-05	6.87e-05	CcSEcCtD
Risperidone—Nausea—Gemcitabine—breast cancer	1.61e-05	6.86e-05	CcSEcCtD
Risperidone—Gastrointestinal disorder—Capecitabine—breast cancer	1.6e-05	6.85e-05	CcSEcCtD
Risperidone—Fatigue—Capecitabine—breast cancer	1.6e-05	6.84e-05	CcSEcCtD
Risperidone—Pruritus—Paclitaxel—breast cancer	1.6e-05	6.84e-05	CcSEcCtD
Risperidone—Vision blurred—Methotrexate—breast cancer	1.6e-05	6.82e-05	CcSEcCtD
Risperidone—Mental disorder—Epirubicin—breast cancer	1.6e-05	6.81e-05	CcSEcCtD
Risperidone—Erythema multiforme—Doxorubicin—breast cancer	1.59e-05	6.8e-05	CcSEcCtD
Risperidone—Pain—Capecitabine—breast cancer	1.59e-05	6.78e-05	CcSEcCtD
Risperidone—Constipation—Capecitabine—breast cancer	1.59e-05	6.78e-05	CcSEcCtD
Risperidone—Erythema—Epirubicin—breast cancer	1.59e-05	6.77e-05	CcSEcCtD
Risperidone—Malnutrition—Epirubicin—breast cancer	1.59e-05	6.77e-05	CcSEcCtD
Risperidone—Feeling abnormal—Docetaxel—breast cancer	1.58e-05	6.75e-05	CcSEcCtD
Risperidone—Nausea—Fluorouracil—breast cancer	1.58e-05	6.74e-05	CcSEcCtD
Risperidone—Eye disorder—Doxorubicin—breast cancer	1.58e-05	6.72e-05	CcSEcCtD
Risperidone—Ill-defined disorder—Methotrexate—breast cancer	1.57e-05	6.71e-05	CcSEcCtD
Risperidone—Tinnitus—Doxorubicin—breast cancer	1.57e-05	6.71e-05	CcSEcCtD
Risperidone—Gastrointestinal pain—Docetaxel—breast cancer	1.57e-05	6.7e-05	CcSEcCtD
Risperidone—Anaemia—Methotrexate—breast cancer	1.57e-05	6.69e-05	CcSEcCtD
Risperidone—Flushing—Doxorubicin—breast cancer	1.57e-05	6.68e-05	CcSEcCtD
Risperidone—Cardiac disorder—Doxorubicin—breast cancer	1.57e-05	6.68e-05	CcSEcCtD
Risperidone—Flatulence—Epirubicin—breast cancer	1.56e-05	6.67e-05	CcSEcCtD
Risperidone—Tension—Epirubicin—breast cancer	1.56e-05	6.64e-05	CcSEcCtD
Risperidone—Dysgeusia—Epirubicin—breast cancer	1.55e-05	6.63e-05	CcSEcCtD
Risperidone—Diarrhoea—Paclitaxel—breast cancer	1.55e-05	6.61e-05	CcSEcCtD
Risperidone—Nervousness—Epirubicin—breast cancer	1.54e-05	6.57e-05	CcSEcCtD
Risperidone—Back pain—Epirubicin—breast cancer	1.53e-05	6.55e-05	CcSEcCtD
Risperidone—Feeling abnormal—Capecitabine—breast cancer	1.53e-05	6.53e-05	CcSEcCtD
Risperidone—Angiopathy—Doxorubicin—breast cancer	1.53e-05	6.53e-05	CcSEcCtD
Risperidone—Malaise—Methotrexate—breast cancer	1.53e-05	6.52e-05	CcSEcCtD
Risperidone—Muscle spasms—Epirubicin—breast cancer	1.53e-05	6.51e-05	CcSEcCtD
Risperidone—Immune system disorder—Doxorubicin—breast cancer	1.52e-05	6.5e-05	CcSEcCtD
Risperidone—Vertigo—Methotrexate—breast cancer	1.52e-05	6.5e-05	CcSEcCtD
Risperidone—Gastrointestinal pain—Capecitabine—breast cancer	1.52e-05	6.48e-05	CcSEcCtD
Risperidone—Mediastinal disorder—Doxorubicin—breast cancer	1.52e-05	6.48e-05	CcSEcCtD
Risperidone—Abdominal pain—Docetaxel—breast cancer	1.52e-05	6.47e-05	CcSEcCtD
Risperidone—Body temperature increased—Docetaxel—breast cancer	1.52e-05	6.47e-05	CcSEcCtD
Risperidone—Leukopenia—Methotrexate—breast cancer	1.52e-05	6.47e-05	CcSEcCtD
Risperidone—Chills—Doxorubicin—breast cancer	1.51e-05	6.46e-05	CcSEcCtD
Risperidone—Arrhythmia—Doxorubicin—breast cancer	1.51e-05	6.43e-05	CcSEcCtD
Risperidone—Dizziness—Paclitaxel—breast cancer	1.5e-05	6.39e-05	CcSEcCtD
Risperidone—Vision blurred—Epirubicin—breast cancer	1.5e-05	6.38e-05	CcSEcCtD
Risperidone—Alopecia—Doxorubicin—breast cancer	1.49e-05	6.36e-05	CcSEcCtD
Risperidone—Cough—Methotrexate—breast cancer	1.48e-05	6.31e-05	CcSEcCtD
Risperidone—Mental disorder—Doxorubicin—breast cancer	1.48e-05	6.3e-05	CcSEcCtD
Risperidone—Urticaria—Capecitabine—breast cancer	1.48e-05	6.3e-05	CcSEcCtD
Risperidone—Ill-defined disorder—Epirubicin—breast cancer	1.47e-05	6.28e-05	CcSEcCtD
Risperidone—Abdominal pain—Capecitabine—breast cancer	1.47e-05	6.27e-05	CcSEcCtD
Risperidone—Body temperature increased—Capecitabine—breast cancer	1.47e-05	6.27e-05	CcSEcCtD
Risperidone—Convulsion—Methotrexate—breast cancer	1.47e-05	6.27e-05	CcSEcCtD
Risperidone—Erythema—Doxorubicin—breast cancer	1.47e-05	6.26e-05	CcSEcCtD
Risperidone—Malnutrition—Doxorubicin—breast cancer	1.47e-05	6.26e-05	CcSEcCtD
Risperidone—Anaemia—Epirubicin—breast cancer	1.47e-05	6.26e-05	CcSEcCtD
Risperidone—Agitation—Epirubicin—breast cancer	1.46e-05	6.22e-05	CcSEcCtD
Risperidone—Flatulence—Doxorubicin—breast cancer	1.45e-05	6.17e-05	CcSEcCtD
Risperidone—Myalgia—Methotrexate—breast cancer	1.44e-05	6.16e-05	CcSEcCtD
Risperidone—Chest pain—Methotrexate—breast cancer	1.44e-05	6.16e-05	CcSEcCtD
Risperidone—Arthralgia—Methotrexate—breast cancer	1.44e-05	6.16e-05	CcSEcCtD
Risperidone—Tension—Doxorubicin—breast cancer	1.44e-05	6.15e-05	CcSEcCtD
Risperidone—Vomiting—Paclitaxel—breast cancer	1.44e-05	6.14e-05	CcSEcCtD
Risperidone—Dysgeusia—Doxorubicin—breast cancer	1.44e-05	6.13e-05	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	1.43e-05	6.12e-05	CcSEcCtD
Risperidone—Malaise—Epirubicin—breast cancer	1.43e-05	6.1e-05	CcSEcCtD
Risperidone—Rash—Paclitaxel—breast cancer	1.43e-05	6.09e-05	CcSEcCtD
Risperidone—Dermatitis—Paclitaxel—breast cancer	1.43e-05	6.09e-05	CcSEcCtD
Risperidone—Discomfort—Methotrexate—breast cancer	1.43e-05	6.08e-05	CcSEcCtD
Risperidone—Nervousness—Doxorubicin—breast cancer	1.43e-05	6.08e-05	CcSEcCtD
Risperidone—Vertigo—Epirubicin—breast cancer	1.43e-05	6.08e-05	CcSEcCtD
Risperidone—Syncope—Epirubicin—breast cancer	1.42e-05	6.07e-05	CcSEcCtD
Risperidone—Leukopenia—Epirubicin—breast cancer	1.42e-05	6.06e-05	CcSEcCtD
Risperidone—Back pain—Doxorubicin—breast cancer	1.42e-05	6.06e-05	CcSEcCtD
Risperidone—Headache—Paclitaxel—breast cancer	1.42e-05	6.05e-05	CcSEcCtD
Risperidone—Hypersensitivity—Docetaxel—breast cancer	1.41e-05	6.03e-05	CcSEcCtD
Risperidone—Muscle spasms—Doxorubicin—breast cancer	1.41e-05	6.02e-05	CcSEcCtD
Risperidone—Palpitations—Epirubicin—breast cancer	1.4e-05	5.98e-05	CcSEcCtD
Risperidone—Confusional state—Methotrexate—breast cancer	1.4e-05	5.95e-05	CcSEcCtD
Risperidone—Loss of consciousness—Epirubicin—breast cancer	1.39e-05	5.95e-05	CcSEcCtD
Risperidone—Cough—Epirubicin—breast cancer	1.38e-05	5.91e-05	CcSEcCtD
Risperidone—Anaphylactic shock—Methotrexate—breast cancer	1.38e-05	5.9e-05	CcSEcCtD
Risperidone—Vision blurred—Doxorubicin—breast cancer	1.38e-05	5.9e-05	CcSEcCtD
Risperidone—Asthenia—Docetaxel—breast cancer	1.38e-05	5.88e-05	CcSEcCtD
Risperidone—Convulsion—Epirubicin—breast cancer	1.37e-05	5.86e-05	CcSEcCtD
Risperidone—Infection—Methotrexate—breast cancer	1.37e-05	5.86e-05	CcSEcCtD
Risperidone—Hypertension—Epirubicin—breast cancer	1.37e-05	5.84e-05	CcSEcCtD
Risperidone—Hypersensitivity—Capecitabine—breast cancer	1.37e-05	5.84e-05	CcSEcCtD
Risperidone—Ill-defined disorder—Doxorubicin—breast cancer	1.36e-05	5.81e-05	CcSEcCtD
Risperidone—Pruritus—Docetaxel—breast cancer	1.36e-05	5.79e-05	CcSEcCtD
Risperidone—Nervous system disorder—Methotrexate—breast cancer	1.36e-05	5.79e-05	CcSEcCtD
Risperidone—Anaemia—Doxorubicin—breast cancer	1.36e-05	5.79e-05	CcSEcCtD
Risperidone—Thrombocytopenia—Methotrexate—breast cancer	1.35e-05	5.78e-05	CcSEcCtD
Risperidone—Chest pain—Epirubicin—breast cancer	1.35e-05	5.76e-05	CcSEcCtD
Risperidone—Myalgia—Epirubicin—breast cancer	1.35e-05	5.76e-05	CcSEcCtD
Risperidone—Arthralgia—Epirubicin—breast cancer	1.35e-05	5.76e-05	CcSEcCtD
Risperidone—Agitation—Doxorubicin—breast cancer	1.35e-05	5.76e-05	CcSEcCtD
Risperidone—Anxiety—Epirubicin—breast cancer	1.35e-05	5.74e-05	CcSEcCtD
Risperidone—Nausea—Paclitaxel—breast cancer	1.35e-05	5.74e-05	CcSEcCtD
Risperidone—Skin disorder—Methotrexate—breast cancer	1.34e-05	5.73e-05	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	1.34e-05	5.72e-05	CcSEcCtD
Risperidone—Hyperhidrosis—Methotrexate—breast cancer	1.34e-05	5.71e-05	CcSEcCtD
Risperidone—Discomfort—Epirubicin—breast cancer	1.33e-05	5.69e-05	CcSEcCtD
Risperidone—Asthenia—Capecitabine—breast cancer	1.33e-05	5.69e-05	CcSEcCtD
Risperidone—Malaise—Doxorubicin—breast cancer	1.32e-05	5.65e-05	CcSEcCtD
Risperidone—Dry mouth—Epirubicin—breast cancer	1.32e-05	5.64e-05	CcSEcCtD
Risperidone—Vertigo—Doxorubicin—breast cancer	1.32e-05	5.63e-05	CcSEcCtD
Risperidone—Anorexia—Methotrexate—breast cancer	1.32e-05	5.63e-05	CcSEcCtD
Risperidone—Syncope—Doxorubicin—breast cancer	1.32e-05	5.62e-05	CcSEcCtD
Risperidone—Pruritus—Capecitabine—breast cancer	1.31e-05	5.61e-05	CcSEcCtD
Risperidone—Leukopenia—Doxorubicin—breast cancer	1.31e-05	5.61e-05	CcSEcCtD
Risperidone—Diarrhoea—Docetaxel—breast cancer	1.31e-05	5.6e-05	CcSEcCtD
Risperidone—Confusional state—Epirubicin—breast cancer	1.31e-05	5.57e-05	CcSEcCtD
Risperidone—Palpitations—Doxorubicin—breast cancer	1.3e-05	5.53e-05	CcSEcCtD
Risperidone—Oedema—Epirubicin—breast cancer	1.29e-05	5.52e-05	CcSEcCtD
Risperidone—Anaphylactic shock—Epirubicin—breast cancer	1.29e-05	5.52e-05	CcSEcCtD
Risperidone—Hypotension—Methotrexate—breast cancer	1.29e-05	5.52e-05	CcSEcCtD
Risperidone—Loss of consciousness—Doxorubicin—breast cancer	1.29e-05	5.5e-05	CcSEcCtD
Risperidone—Infection—Epirubicin—breast cancer	1.29e-05	5.49e-05	CcSEcCtD
Risperidone—Cough—Doxorubicin—breast cancer	1.28e-05	5.47e-05	CcSEcCtD
Risperidone—Shock—Epirubicin—breast cancer	1.27e-05	5.44e-05	CcSEcCtD
Risperidone—Convulsion—Doxorubicin—breast cancer	1.27e-05	5.43e-05	CcSEcCtD
Risperidone—Diarrhoea—Capecitabine—breast cancer	1.27e-05	5.43e-05	CcSEcCtD
Risperidone—Nervous system disorder—Epirubicin—breast cancer	1.27e-05	5.42e-05	CcSEcCtD
Risperidone—Dizziness—Docetaxel—breast cancer	1.27e-05	5.42e-05	CcSEcCtD
Risperidone—Thrombocytopenia—Epirubicin—breast cancer	1.27e-05	5.41e-05	CcSEcCtD
Risperidone—Hypertension—Doxorubicin—breast cancer	1.27e-05	5.41e-05	CcSEcCtD
Risperidone—Tachycardia—Epirubicin—breast cancer	1.26e-05	5.39e-05	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Methotrexate—breast cancer	1.26e-05	5.38e-05	CcSEcCtD
Risperidone—Skin disorder—Epirubicin—breast cancer	1.26e-05	5.37e-05	CcSEcCtD
Risperidone—Hyperhidrosis—Epirubicin—breast cancer	1.25e-05	5.34e-05	CcSEcCtD
Risperidone—Insomnia—Methotrexate—breast cancer	1.25e-05	5.34e-05	CcSEcCtD
Risperidone—Chest pain—Doxorubicin—breast cancer	1.25e-05	5.33e-05	CcSEcCtD
Risperidone—Myalgia—Doxorubicin—breast cancer	1.25e-05	5.33e-05	CcSEcCtD
Risperidone—Arthralgia—Doxorubicin—breast cancer	1.25e-05	5.33e-05	CcSEcCtD
Risperidone—Anxiety—Doxorubicin—breast cancer	1.25e-05	5.31e-05	CcSEcCtD
Risperidone—Paraesthesia—Methotrexate—breast cancer	1.24e-05	5.3e-05	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	1.24e-05	5.3e-05	CcSEcCtD
Risperidone—Discomfort—Doxorubicin—breast cancer	1.23e-05	5.27e-05	CcSEcCtD
Risperidone—Anorexia—Epirubicin—breast cancer	1.23e-05	5.27e-05	CcSEcCtD
Risperidone—Dyspnoea—Methotrexate—breast cancer	1.23e-05	5.26e-05	CcSEcCtD
Risperidone—Somnolence—Methotrexate—breast cancer	1.23e-05	5.25e-05	CcSEcCtD
Risperidone—Dizziness—Capecitabine—breast cancer	1.23e-05	5.24e-05	CcSEcCtD
Risperidone—Dry mouth—Doxorubicin—breast cancer	1.22e-05	5.21e-05	CcSEcCtD
Risperidone—Vomiting—Docetaxel—breast cancer	1.22e-05	5.21e-05	CcSEcCtD
Risperidone—Dyspepsia—Methotrexate—breast cancer	1.22e-05	5.2e-05	CcSEcCtD
Risperidone—Rash—Docetaxel—breast cancer	1.21e-05	5.16e-05	CcSEcCtD
Risperidone—Hypotension—Epirubicin—breast cancer	1.21e-05	5.16e-05	CcSEcCtD
Risperidone—Dermatitis—Docetaxel—breast cancer	1.21e-05	5.16e-05	CcSEcCtD
Risperidone—Confusional state—Doxorubicin—breast cancer	1.21e-05	5.15e-05	CcSEcCtD
Risperidone—Decreased appetite—Methotrexate—breast cancer	1.2e-05	5.13e-05	CcSEcCtD
Risperidone—Headache—Docetaxel—breast cancer	1.2e-05	5.13e-05	CcSEcCtD
Risperidone—Anaphylactic shock—Doxorubicin—breast cancer	1.2e-05	5.11e-05	CcSEcCtD
Risperidone—Oedema—Doxorubicin—breast cancer	1.2e-05	5.11e-05	CcSEcCtD
Risperidone—Gastrointestinal disorder—Methotrexate—breast cancer	1.19e-05	5.1e-05	CcSEcCtD
Risperidone—Fatigue—Methotrexate—breast cancer	1.19e-05	5.09e-05	CcSEcCtD
Risperidone—Infection—Doxorubicin—breast cancer	1.19e-05	5.08e-05	CcSEcCtD
Risperidone—Pain—Methotrexate—breast cancer	1.18e-05	5.05e-05	CcSEcCtD
Risperidone—Vomiting—Capecitabine—breast cancer	1.18e-05	5.04e-05	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Epirubicin—breast cancer	1.18e-05	5.03e-05	CcSEcCtD
Risperidone—Shock—Doxorubicin—breast cancer	1.18e-05	5.03e-05	CcSEcCtD
Risperidone—Nervous system disorder—Doxorubicin—breast cancer	1.17e-05	5.01e-05	CcSEcCtD
Risperidone—Thrombocytopenia—Doxorubicin—breast cancer	1.17e-05	5e-05	CcSEcCtD
Risperidone—Rash—Capecitabine—breast cancer	1.17e-05	5e-05	CcSEcCtD
Risperidone—Insomnia—Epirubicin—breast cancer	1.17e-05	5e-05	CcSEcCtD
Risperidone—Dermatitis—Capecitabine—breast cancer	1.17e-05	5e-05	CcSEcCtD
Risperidone—Tachycardia—Doxorubicin—breast cancer	1.17e-05	4.99e-05	CcSEcCtD
Risperidone—Headache—Capecitabine—breast cancer	1.16e-05	4.97e-05	CcSEcCtD
Risperidone—Skin disorder—Doxorubicin—breast cancer	1.16e-05	4.97e-05	CcSEcCtD
Risperidone—Paraesthesia—Epirubicin—breast cancer	1.16e-05	4.96e-05	CcSEcCtD
Risperidone—Hyperhidrosis—Doxorubicin—breast cancer	1.16e-05	4.94e-05	CcSEcCtD
Risperidone—Dyspnoea—Epirubicin—breast cancer	1.15e-05	4.93e-05	CcSEcCtD
Risperidone—Somnolence—Epirubicin—breast cancer	1.15e-05	4.91e-05	CcSEcCtD
Risperidone—Anorexia—Doxorubicin—breast cancer	1.14e-05	4.87e-05	CcSEcCtD
Risperidone—Nausea—Docetaxel—breast cancer	1.14e-05	4.87e-05	CcSEcCtD
Risperidone—Feeling abnormal—Methotrexate—breast cancer	1.14e-05	4.86e-05	CcSEcCtD
Risperidone—Dyspepsia—Epirubicin—breast cancer	1.14e-05	4.86e-05	CcSEcCtD
Risperidone—Gastrointestinal pain—Methotrexate—breast cancer	1.13e-05	4.83e-05	CcSEcCtD
Risperidone—Decreased appetite—Epirubicin—breast cancer	1.13e-05	4.8e-05	CcSEcCtD
Risperidone—Hypotension—Doxorubicin—breast cancer	1.12e-05	4.78e-05	CcSEcCtD
Risperidone—Gastrointestinal disorder—Epirubicin—breast cancer	1.12e-05	4.77e-05	CcSEcCtD
Risperidone—Fatigue—Epirubicin—breast cancer	1.12e-05	4.76e-05	CcSEcCtD
Risperidone—Pain—Epirubicin—breast cancer	1.11e-05	4.72e-05	CcSEcCtD
Risperidone—Constipation—Epirubicin—breast cancer	1.11e-05	4.72e-05	CcSEcCtD
Risperidone—Nausea—Capecitabine—breast cancer	1.1e-05	4.71e-05	CcSEcCtD
Risperidone—Urticaria—Methotrexate—breast cancer	1.1e-05	4.69e-05	CcSEcCtD
Risperidone—Abdominal pain—Methotrexate—breast cancer	1.09e-05	4.67e-05	CcSEcCtD
Risperidone—Body temperature increased—Methotrexate—breast cancer	1.09e-05	4.67e-05	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.09e-05	4.66e-05	CcSEcCtD
Risperidone—Insomnia—Doxorubicin—breast cancer	1.08e-05	4.62e-05	CcSEcCtD
Risperidone—Paraesthesia—Doxorubicin—breast cancer	1.08e-05	4.59e-05	CcSEcCtD
Risperidone—Dyspnoea—Doxorubicin—breast cancer	1.07e-05	4.56e-05	CcSEcCtD
Risperidone—Feeling abnormal—Epirubicin—breast cancer	1.07e-05	4.55e-05	CcSEcCtD
Risperidone—Somnolence—Doxorubicin—breast cancer	1.07e-05	4.54e-05	CcSEcCtD
Risperidone—Gastrointestinal pain—Epirubicin—breast cancer	1.06e-05	4.52e-05	CcSEcCtD
Risperidone—Dyspepsia—Doxorubicin—breast cancer	1.05e-05	4.5e-05	CcSEcCtD
Risperidone—Decreased appetite—Doxorubicin—breast cancer	1.04e-05	4.44e-05	CcSEcCtD
Risperidone—Gastrointestinal disorder—Doxorubicin—breast cancer	1.03e-05	4.41e-05	CcSEcCtD
Risperidone—Fatigue—Doxorubicin—breast cancer	1.03e-05	4.41e-05	CcSEcCtD
Risperidone—Urticaria—Epirubicin—breast cancer	1.03e-05	4.39e-05	CcSEcCtD
Risperidone—Pain—Doxorubicin—breast cancer	1.02e-05	4.37e-05	CcSEcCtD
Risperidone—Constipation—Doxorubicin—breast cancer	1.02e-05	4.37e-05	CcSEcCtD
Risperidone—Abdominal pain—Epirubicin—breast cancer	1.02e-05	4.37e-05	CcSEcCtD
Risperidone—Body temperature increased—Epirubicin—breast cancer	1.02e-05	4.37e-05	CcSEcCtD
Risperidone—Hypersensitivity—Methotrexate—breast cancer	1.02e-05	4.35e-05	CcSEcCtD
Risperidone—Asthenia—Methotrexate—breast cancer	9.93e-06	4.24e-05	CcSEcCtD
Risperidone—Feeling abnormal—Doxorubicin—breast cancer	9.87e-06	4.21e-05	CcSEcCtD
Risperidone—Gastrointestinal pain—Doxorubicin—breast cancer	9.8e-06	4.18e-05	CcSEcCtD
Risperidone—Pruritus—Methotrexate—breast cancer	9.79e-06	4.18e-05	CcSEcCtD
Risperidone—Hypersensitivity—Epirubicin—breast cancer	9.54e-06	4.07e-05	CcSEcCtD
Risperidone—Urticaria—Doxorubicin—breast cancer	9.52e-06	4.06e-05	CcSEcCtD
Risperidone—Abdominal pain—Doxorubicin—breast cancer	9.47e-06	4.04e-05	CcSEcCtD
Risperidone—Body temperature increased—Doxorubicin—breast cancer	9.47e-06	4.04e-05	CcSEcCtD
Risperidone—Diarrhoea—Methotrexate—breast cancer	9.47e-06	4.04e-05	CcSEcCtD
Risperidone—Asthenia—Epirubicin—breast cancer	9.29e-06	3.96e-05	CcSEcCtD
Risperidone—Pruritus—Epirubicin—breast cancer	9.16e-06	3.91e-05	CcSEcCtD
Risperidone—Dizziness—Methotrexate—breast cancer	9.15e-06	3.9e-05	CcSEcCtD
Risperidone—Diarrhoea—Epirubicin—breast cancer	8.86e-06	3.78e-05	CcSEcCtD
Risperidone—Hypersensitivity—Doxorubicin—breast cancer	8.83e-06	3.77e-05	CcSEcCtD
Risperidone—Vomiting—Methotrexate—breast cancer	8.8e-06	3.75e-05	CcSEcCtD
Risperidone—Rash—Methotrexate—breast cancer	8.72e-06	3.72e-05	CcSEcCtD
Risperidone—Dermatitis—Methotrexate—breast cancer	8.72e-06	3.72e-05	CcSEcCtD
Risperidone—Headache—Methotrexate—breast cancer	8.67e-06	3.7e-05	CcSEcCtD
Risperidone—Asthenia—Doxorubicin—breast cancer	8.6e-06	3.67e-05	CcSEcCtD
Risperidone—Dizziness—Epirubicin—breast cancer	8.56e-06	3.65e-05	CcSEcCtD
Risperidone—Pruritus—Doxorubicin—breast cancer	8.48e-06	3.62e-05	CcSEcCtD
Risperidone—Vomiting—Epirubicin—breast cancer	8.23e-06	3.51e-05	CcSEcCtD
Risperidone—Nausea—Methotrexate—breast cancer	8.22e-06	3.51e-05	CcSEcCtD
Risperidone—Diarrhoea—Doxorubicin—breast cancer	8.2e-06	3.5e-05	CcSEcCtD
Risperidone—Rash—Epirubicin—breast cancer	8.16e-06	3.48e-05	CcSEcCtD
Risperidone—Dermatitis—Epirubicin—breast cancer	8.16e-06	3.48e-05	CcSEcCtD
Risperidone—Headache—Epirubicin—breast cancer	8.11e-06	3.46e-05	CcSEcCtD
Risperidone—Dizziness—Doxorubicin—breast cancer	7.92e-06	3.38e-05	CcSEcCtD
Risperidone—Nausea—Epirubicin—breast cancer	7.69e-06	3.28e-05	CcSEcCtD
Risperidone—Vomiting—Doxorubicin—breast cancer	7.62e-06	3.25e-05	CcSEcCtD
Risperidone—Rash—Doxorubicin—breast cancer	7.55e-06	3.22e-05	CcSEcCtD
Risperidone—Dermatitis—Doxorubicin—breast cancer	7.55e-06	3.22e-05	CcSEcCtD
Risperidone—Headache—Doxorubicin—breast cancer	7.51e-06	3.2e-05	CcSEcCtD
Risperidone—Nausea—Doxorubicin—breast cancer	7.12e-06	3.04e-05	CcSEcCtD
Risperidone—ADRA1A—Signaling Pathways—CASP3—breast cancer	1.36e-06	1.3e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—IL2—breast cancer	1.36e-06	1.3e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—VEGFA—breast cancer	1.36e-06	1.3e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—SRC—breast cancer	1.36e-06	1.3e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—TP53—breast cancer	1.36e-06	1.3e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CCND1—breast cancer	1.36e-06	1.3e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—IL6—breast cancer	1.36e-06	1.3e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—STAT3—breast cancer	1.36e-06	1.3e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—JUN—breast cancer	1.35e-06	1.29e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CCND1—breast cancer	1.35e-06	1.29e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—KRAS—breast cancer	1.35e-06	1.29e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—JUN—breast cancer	1.35e-06	1.29e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—COMT—breast cancer	1.35e-06	1.29e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—STAT3—breast cancer	1.35e-06	1.29e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CTNNB1—breast cancer	1.34e-06	1.28e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—GSTP1—breast cancer	1.34e-06	1.28e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—MAPK3—breast cancer	1.34e-06	1.28e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CTNNB1—breast cancer	1.34e-06	1.28e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—SRC—breast cancer	1.34e-06	1.28e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—MMP9—breast cancer	1.34e-06	1.28e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—TP53—breast cancer	1.34e-06	1.28e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—KRAS—breast cancer	1.34e-06	1.28e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—HRAS—breast cancer	1.33e-06	1.28e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CDKN1A—breast cancer	1.33e-06	1.27e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—PTEN—breast cancer	1.33e-06	1.27e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CCND1—breast cancer	1.33e-06	1.27e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—HRAS—breast cancer	1.33e-06	1.27e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—JUN—breast cancer	1.33e-06	1.27e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—HMOX1—breast cancer	1.32e-06	1.27e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CXCL8—breast cancer	1.32e-06	1.27e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—VEGFA—breast cancer	1.32e-06	1.27e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—ITPR1—breast cancer	1.32e-06	1.26e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—PIK3CA—breast cancer	1.32e-06	1.26e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—MMP9—breast cancer	1.32e-06	1.26e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—HRAS—breast cancer	1.32e-06	1.26e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CTNNB1—breast cancer	1.32e-06	1.26e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—MMP9—breast cancer	1.31e-06	1.26e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CDKN1A—breast cancer	1.31e-06	1.25e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—STAT3—breast cancer	1.31e-06	1.25e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CDKN1A—breast cancer	1.31e-06	1.25e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—PTEN—breast cancer	1.31e-06	1.25e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PIK3CD—breast cancer	1.31e-06	1.25e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—PTEN—breast cancer	1.31e-06	1.25e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—PTEN—breast cancer	1.31e-06	1.25e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—MYC—breast cancer	1.3e-06	1.25e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—VEGFA—breast cancer	1.3e-06	1.25e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—MAPK8—breast cancer	1.3e-06	1.24e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—TGFB1—breast cancer	1.3e-06	1.24e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—HRAS—breast cancer	1.3e-06	1.24e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—AKT1—breast cancer	1.3e-06	1.24e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—MAPK3—breast cancer	1.3e-06	1.24e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CDKN1B—breast cancer	1.29e-06	1.24e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—ALB—breast cancer	1.29e-06	1.23e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—STAT3—breast cancer	1.29e-06	1.23e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—MMP9—breast cancer	1.29e-06	1.23e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—MAPK3—breast cancer	1.29e-06	1.23e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CDKN1A—breast cancer	1.29e-06	1.23e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—PTEN—breast cancer	1.28e-06	1.23e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—MAPK8—breast cancer	1.28e-06	1.22e-05	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—AKT1—breast cancer	1.28e-06	1.22e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—MAPK8—breast cancer	1.28e-06	1.22e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—HRAS—breast cancer	1.28e-06	1.22e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—IL6—breast cancer	1.28e-06	1.22e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—AKT1—breast cancer	1.28e-06	1.22e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—EGFR—breast cancer	1.28e-06	1.22e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—TP53—breast cancer	1.28e-06	1.22e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—AKT1—breast cancer	1.27e-06	1.22e-05	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—PIK3CA—breast cancer	1.27e-06	1.22e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—ABCB1—breast cancer	1.27e-06	1.22e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—IL6—breast cancer	1.27e-06	1.21e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CASP3—breast cancer	1.27e-06	1.21e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—IL2—breast cancer	1.27e-06	1.21e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—IL6—breast cancer	1.26e-06	1.2e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—MYC—breast cancer	1.26e-06	1.2e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—TGFB1—breast cancer	1.26e-06	1.2e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—MAPK8—breast cancer	1.25e-06	1.2e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—MAPK3—breast cancer	1.25e-06	1.2e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—MYC—breast cancer	1.25e-06	1.2e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—AKT1—breast cancer	1.25e-06	1.2e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—TGFB1—breast cancer	1.25e-06	1.19e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—TYMS—breast cancer	1.25e-06	1.19e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—PIK3CA—breast cancer	1.24e-06	1.19e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—IL6—breast cancer	1.24e-06	1.19e-05	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—PIK3CA—breast cancer	1.24e-06	1.18e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—NOS3—breast cancer	1.24e-06	1.18e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—NCOR1—breast cancer	1.23e-06	1.18e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—GSTM1—breast cancer	1.23e-06	1.18e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.23e-06	1.18e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CCND1—breast cancer	1.23e-06	1.18e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—SRC—breast cancer	1.23e-06	1.18e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—MAPK3—breast cancer	1.23e-06	1.18e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PIK3CD—breast cancer	1.23e-06	1.18e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—EGFR—breast cancer	1.23e-06	1.18e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—JUN—breast cancer	1.23e-06	1.18e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—PIK3CA—breast cancer	1.23e-06	1.17e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—EGFR—breast cancer	1.23e-06	1.17e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—IL6—breast cancer	1.22e-06	1.17e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CTNNB1—breast cancer	1.22e-06	1.17e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—HRAS—breast cancer	1.22e-06	1.17e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—MYC—breast cancer	1.22e-06	1.16e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—ALB—breast cancer	1.22e-06	1.16e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—TGFB1—breast cancer	1.22e-06	1.16e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—SRC—breast cancer	1.21e-06	1.16e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—SRC—breast cancer	1.21e-06	1.16e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—KRAS—breast cancer	1.21e-06	1.15e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—TP53—breast cancer	1.2e-06	1.15e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—VEGFA—breast cancer	1.2e-06	1.15e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—MYC—breast cancer	1.2e-06	1.15e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—MMP9—breast cancer	1.2e-06	1.15e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—TGFB1—breast cancer	1.2e-06	1.14e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CDKN1A—breast cancer	1.19e-06	1.14e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—EGFR—breast cancer	1.19e-06	1.14e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—PTEN—breast cancer	1.19e-06	1.14e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—STAT3—breast cancer	1.19e-06	1.14e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—SRC—breast cancer	1.19e-06	1.14e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—TP53—breast cancer	1.19e-06	1.13e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—VEGFA—breast cancer	1.18e-06	1.13e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—GPX1—breast cancer	1.18e-06	1.13e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—VEGFA—breast cancer	1.18e-06	1.13e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—AKT1—breast cancer	1.18e-06	1.13e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—EGFR—breast cancer	1.17e-06	1.12e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—STAT3—breast cancer	1.17e-06	1.12e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—AKT1—breast cancer	1.17e-06	1.12e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CYP1A1—breast cancer	1.17e-06	1.12e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—STAT3—breast cancer	1.17e-06	1.12e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—IL6—breast cancer	1.17e-06	1.12e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—MAPK8—breast cancer	1.17e-06	1.11e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—NOS3—breast cancer	1.16e-06	1.11e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—KRAS—breast cancer	1.16e-06	1.11e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—AKT1—breast cancer	1.16e-06	1.11e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—ERCC2—breast cancer	1.16e-06	1.11e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—VEGFA—breast cancer	1.16e-06	1.11e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—KRAS—breast cancer	1.16e-06	1.11e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—HRAS—breast cancer	1.15e-06	1.1e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—STAT3—breast cancer	1.15e-06	1.1e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—AKT1—breast cancer	1.15e-06	1.1e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PIK3CB—breast cancer	1.14e-06	1.09e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—MAPK3—breast cancer	1.14e-06	1.09e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—HRAS—breast cancer	1.14e-06	1.08e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PTGS2—breast cancer	1.13e-06	1.08e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—AKT1—breast cancer	1.13e-06	1.08e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—KRAS—breast cancer	1.13e-06	1.08e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—MAPK3—breast cancer	1.12e-06	1.07e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—MAPK3—breast cancer	1.12e-06	1.07e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—KRAS—breast cancer	1.11e-06	1.06e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—PIK3CA—breast cancer	1.11e-06	1.06e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—MYC—breast cancer	1.11e-06	1.06e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—SRC—breast cancer	1.1e-06	1.06e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—TGFB1—breast cancer	1.1e-06	1.05e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—IL6—breast cancer	1.1e-06	1.05e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—MAPK3—breast cancer	1.1e-06	1.05e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—MTHFR—breast cancer	1.09e-06	1.04e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—MYC—breast cancer	1.09e-06	1.04e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—IL6—breast cancer	1.09e-06	1.04e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—MYC—breast cancer	1.09e-06	1.04e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—TGFB1—breast cancer	1.09e-06	1.04e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—TGFB1—breast cancer	1.08e-06	1.04e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—EGFR—breast cancer	1.08e-06	1.03e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—AKT1—breast cancer	1.08e-06	1.03e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—VEGFA—breast cancer	1.08e-06	1.03e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PIK3CB—breast cancer	1.07e-06	1.03e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—TP53—breast cancer	1.07e-06	1.02e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—PIK3CA—breast cancer	1.07e-06	1.02e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—MYC—breast cancer	1.07e-06	1.02e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—STAT3—breast cancer	1.07e-06	1.02e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PTGS2—breast cancer	1.06e-06	1.02e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—EGFR—breast cancer	1.06e-06	1.02e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—PIK3CA—breast cancer	1.06e-06	1.02e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—TGFB1—breast cancer	1.06e-06	1.02e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—EGFR—breast cancer	1.06e-06	1.02e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—EGFR—breast cancer	1.04e-06	9.96e-06	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—AKT1—breast cancer	1.04e-06	9.95e-06	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—PIK3CA—breast cancer	1.03e-06	9.89e-06	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—TP53—breast cancer	1.03e-06	9.89e-06	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—TP53—breast cancer	1.03e-06	9.84e-06	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—HRAS—breast cancer	1.02e-06	9.8e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—KRAS—breast cancer	1.02e-06	9.77e-06	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—PIK3CA—breast cancer	1.02e-06	9.73e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—MAPK3—breast cancer	1.02e-06	9.73e-06	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—AKT1—breast cancer	1.02e-06	9.71e-06	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—AKT1—breast cancer	1.01e-06	9.66e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CAV1—breast cancer	1.01e-06	9.62e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—KRAS—breast cancer	1.01e-06	9.61e-06	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—PIK3CA—breast cancer	1.01e-06	9.61e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—KRAS—breast cancer	1e-06	9.59e-06	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—AKT1—breast cancer	1e-06	9.58e-06	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—TP53—breast cancer	1e-06	9.57e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—MYC—breast cancer	9.9e-07	9.46e-06	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—HRAS—breast cancer	9.89e-07	9.46e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—TGFB1—breast cancer	9.88e-07	9.44e-06	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PTEN—breast cancer	9.85e-07	9.42e-06	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—TP53—breast cancer	9.85e-07	9.42e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—KRAS—breast cancer	9.84e-07	9.41e-06	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—HRAS—breast cancer	9.84e-07	9.41e-06	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—IL6—breast cancer	9.81e-07	9.37e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—EGFR—breast cancer	9.68e-07	9.26e-06	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—HRAS—breast cancer	9.57e-07	9.15e-06	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—IL6—breast cancer	9.47e-07	9.05e-06	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—HRAS—breast cancer	9.42e-07	9e-06	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—IL6—breast cancer	9.42e-07	9e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—PIK3CA—breast cancer	9.39e-07	8.97e-06	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PTEN—breast cancer	9.28e-07	8.87e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—PIK3CA—breast cancer	9.24e-07	8.83e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—PIK3CA—breast cancer	9.22e-07	8.81e-06	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—PIK3CA—breast cancer	9.21e-07	8.8e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PIK3CG—breast cancer	9.17e-07	8.76e-06	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—IL6—breast cancer	9.16e-07	8.76e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—KRAS—breast cancer	9.15e-07	8.74e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—TP53—breast cancer	9.08e-07	8.68e-06	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—AKT1—breast cancer	9.05e-07	8.65e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—PIK3CA—breast cancer	9.04e-07	8.65e-06	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—IL6—breast cancer	9.02e-07	8.62e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—TP53—breast cancer	8.94e-07	8.54e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—TP53—breast cancer	8.92e-07	8.52e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—TP53—breast cancer	8.75e-07	8.36e-06	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—AKT1—breast cancer	8.73e-07	8.35e-06	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—AKT1—breast cancer	8.69e-07	8.31e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—HRAS—breast cancer	8.69e-07	8.3e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—HRAS—breast cancer	8.55e-07	8.17e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—HRAS—breast cancer	8.53e-07	8.15e-06	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—AKT1—breast cancer	8.45e-07	8.08e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—PIK3CA—breast cancer	8.4e-07	8.03e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—HRAS—breast cancer	8.37e-07	8e-06	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—AKT1—breast cancer	8.32e-07	7.95e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—IL6—breast cancer	8.31e-07	7.95e-06	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—AKT1—breast cancer	8.21e-07	7.85e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—IL6—breast cancer	8.18e-07	7.82e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—IL6—breast cancer	8.16e-07	7.8e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—TP53—breast cancer	8.13e-07	7.77e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PIK3CD—breast cancer	8.06e-07	7.7e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—IL6—breast cancer	8.01e-07	7.66e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—ALB—breast cancer	7.96e-07	7.6e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—HRAS—breast cancer	7.78e-07	7.43e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—AKT1—breast cancer	7.67e-07	7.33e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—NOS3—breast cancer	7.61e-07	7.27e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—AKT1—breast cancer	7.55e-07	7.21e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—AKT1—breast cancer	7.53e-07	7.2e-06	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—AKT1—breast cancer	7.52e-07	7.19e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—IL6—breast cancer	7.44e-07	7.11e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—AKT1—breast cancer	7.39e-07	7.06e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PIK3CB—breast cancer	7.02e-07	6.71e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PTGS2—breast cancer	6.96e-07	6.65e-06	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PIK3CA—breast cancer	6.95e-07	6.64e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—AKT1—breast cancer	6.87e-07	6.56e-06	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PIK3CA—breast cancer	6.55e-07	6.26e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PTEN—breast cancer	6.07e-07	5.8e-06	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—AKT1—breast cancer	5.68e-07	5.43e-06	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—AKT1—breast cancer	5.35e-07	5.11e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PIK3CA—breast cancer	4.28e-07	4.09e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—AKT1—breast cancer	3.5e-07	3.34e-06	CbGpPWpGaD
